Verification simulation kit for single cell sequencing instrument and use method of verification simulation kit

By providing a single-cell sequencing instrument verification simulation kit containing simulated microspheres, simulated cell phases and simulated reverse transcription reagents, the problem of real reagent waste and high cost is solved, and efficient verification at room temperature is achieved and operation is simplified. And reduce verification costs.

CN118909758APending Publication Date: 2024-11-08MOBIDROP (ZHEJIANG) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411085161.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-08
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The use of real reagents is required during the verification process of existing single-cell sequencing instruments, resulting in waste of resources, increased verification costs and time, which is especially unfavorable to the development of small equipment manufacturers.

Method used

Provide a single-cell sequencing instrument verification simulation kit, including simulated microspheres, simulated cell phases and simulated reverse transcription reagents. The simulated microspheres do not contain capture oligonucleotides, simulated reverse transcription reagents do not contain active enzymes, simulated The cell phase is cell-free and can be stored and used at room temperature. By adding PEG600, glycerol and nonionic surfactants, the density and viscosity are simulated to ensure that the chemical reaction characteristics are similar to that of the real reagent.

Benefits of technology

It reduces verification costs and time, realizes verification at room temperature, simplifies operations, improves verification efficiency, and allows relevant personnel with weak biological skills to be proficient in using it. It is suitable as a training kit.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909758A_ABST
    Figure CN118909758A_ABST
Patent Text Reader

Abstract

The present invention provides a single cell sequencing instrument verification simulation kit and a use method thereof, the single cell sequencing instrument verification simulation kit comprises a simulation microsphere, a simulation cell phase, a simulation reverse transcription reagent and simulation droplet generation oil, the simulation microsphere does not contain capture oligonucleotide, and the simulation cell phase does not contain capture oligonucleotide. The simulated reverse transcription reagent does not contain active enzyme, and the simulated cell phase does not contain cells. The single cell sequencing instrument verification simulation kit can highly simulate a real reagent physically and chemically, and ensures that a test effect conforming to an actual use environment is achieved in a verification process, so that the verification cost is reduced, and the verification efficiency is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of single-cell sequencing, and in particular to a single-cell sequencing instrument verification simulation kit and a method for using the same. Background Art

[0002] High-throughput single-cell sequencing technology occupies an important position in today's biomedical research. But no matter which technology the single-cell sequencing technology is based on, it requires the use of reagent kits and instruments. However, its market promotion and wide application have put forward higher requirements on the performance and stability of the equipment. In the existing instrument production process, in addition to the intermediate process detection and other steps, the performance of the instrument itself is tested, and real reagents are usually required to complete the complete experimental process and conduct repeated tests to verify the various performances of the instrument and reagents. This not only consumes a lot of resources, but also increases the verification cost and time. In addition, in the early stage of production, the high cost of the equipment verification process has also hindered the development of many small equipment manufacturers. Therefore, it is particularly important to find a simulation kit that can simulate the real experimental environment and is efficient and economical. Summary of the invention

[0003] In view of the above-mentioned shortcomings of the prior art, the purpose of the present invention is to provide a single-cell sequencing instrument verification simulation kit and a method of using the same, so as to solve the problem that the existing single-cell sequencing instrument verification uses a real kit, which consumes a lot of resources and increases the verification cost and verification time.

[0004] To achieve the above-mentioned purpose and other related purposes, the present invention provides a single-cell sequencing instrument verification simulation kit, comprising simulated microspheres, a simulated cell phase, a simulated reverse transcription reagent and a simulated droplet generation oil, wherein the simulated microspheres do not contain capture oligonucleotides (hereinafter referred to as oligo), the simulated reverse transcription reagent does not contain active enzymes, and the simulated cell phase does not contain cells.

[0005] In the prior art, the real single-cell sequencing instrument verification kit contains specially modified capture oligonucleotides and active enzymes. In order to test the accuracy of the data, the structural stability and activity of the above components must be guaranteed. The above substances generally need to be stored at -80 or -20°C, and the storage environment requirements are high. At the same time, in order to ensure cell activity, the kit needs to be thawed on ice at 4°C before use. The single-cell sequencing instrument verification simulation kit proposed in this application does not contain capture oligonucleotides in the simulated microspheres, does not contain active enzymes in the simulated reverse transcription reagents, and does not contain cells in the simulated cell phase, so it can be stored and used at room temperature.

[0006] Oligo refers to oligonucleotide chains. PCR primers, NGS capture probes, qPCR probes and FISH probes commonly used in molecular laboratories are all oligonucleotides. In addition to primers and probes, they can also be used as nucleic acid drugs for the treatment or prevention of genetic diseases, tumors, viral infections and sensory organ diseases. Preferably, the simulated microspheres are hydrogel microspheres that do not contain capture oligonucleotides.

[0007] Preferably, the particle size of the hydrogel microspheres is generally in the range of several micrometers to several hundred micrometers, and the particle size is uniform, such as 5 μm to 800 μm.

[0008] Preferably, the simulated cell phase consists of the following components in percentage by weight: 75-85% phosphate buffered saline (PBS), 10-20% density gradient culture medium (optiprep, opt) and 2-5% polyethylene glycol.

[0009] Preferably, the simulated reverse transcription reagent comprises a simulated reverse transcription primer, a simulated reverse transcription buffer and a simulated reverse transcriptase mixture.

[0010] Preferably, the simulated reverse transcription primer is a mixture of Tris-HCl at a concentration of 10-15 mM and EDTA at a concentration of 0.1-0.2 mM.

[0011] Preferably, the simulated reverse transcription buffer comprises the following components: 75-100 mM Tris-HCl (Tris-HCl) with a pH of 8.3, 150-200 mM KCL, 5-7 mM MgCl2, 20-25 mM DTT, 0.1-0.25 Vol % non-ionic surfactant and 2-5 mM dNTP Mix solution. Wherein, 0.1-0.25 Vol % non-ionic surfactant means that the volume fraction of the non-ionic surfactant in the simulated reverse transcription buffer is 0.1-0.25 Vol %.

[0012] More preferably, the dNTP Mix solution is an equimolar mixture of dATP, dCTP, dGTP and dTTP, and the final concentration of each nucleic acid solution is 25 mM.

[0013] More preferably, the simulated reverse transcriptase mixture comprises the following components: 10-15 mM EDTA; 30-40 mM NaCl, 15-20 mM Tris-HCl at pH 7.5, 5-10 mM Tris-HCl at pH 8.0, 0.003-0.05 Vol % nonionic surfactant, 3-5 mM DTT, 30-55 Vol % glycerol, 10-15 mM KCl, 20-30 Vol % polyethylene glycol. Preferably, the polyethylene glycol is PEG600.

[0014] More preferably, the nonionic surfactant is CA630.

[0015] The present invention achieves a density close to that of a real reagent by adding PEG600 and glycerol thickeners and adjusting the liquid components; by adding PEG600 and glycerol thickeners, the reagent exhibits a viscosity close to that of a real reagent during use; and by adding the key component of non-ionic surfactant CA630, the chemical reaction characteristics similar to those of a real reagent during the sequencing process are ensured.

[0016] Preferably, the simulated droplet generation oil is a fluorinated surfactant, and specifically HFE7500 fluorinated oil can be used.

[0017] Compared with mineral oil, fluorinated liquid HFE-7500 has the advantages of low viscosity, good compatibility with PDMS, low migration between droplets, good gas solubility, long-term biocompatibility, etc. In addition, fluorinated surfactants have a good effect on the stability of the oil-water interface, and the droplets prepared using this product can be stably stored for several weeks.

[0018] The present application also provides a single-cell sequencing instrument verification simulation kit for verifying the use of a single-cell sequencing instrument.

[0019] The present application also provides a method for using a single-cell sequencing instrument verification simulation kit, which is used in conjunction with a high-throughput single-cell instrument, comprising the following steps: adding the components of the above-mentioned single-cell sequencing instrument verification simulation kit to the chip of the high-throughput single-cell instrument, running the high-throughput single-cell instrument, and performing quality inspection on the running results.

[0020] As described above, the single-cell sequencing instrument verification simulation kit and the use method thereof of the present invention have the following beneficial effects: (1) A simulation kit for production verification of high-throughput single-cell sequencing instruments is provided. The kit can highly simulate the real reagents in terms of physical and chemical properties, ensuring that the test results consistent with the actual use environment are achieved during the verification process, thereby reducing verification costs and improving verification efficiency; (2) It provides a simulated test kit that can be stored at room temperature. This is different from the real experimental reagents that often need to be stored at low temperatures and are difficult to transport. The room temperature storage and transportation of this test kit greatly reduces the cost. It is also a test kit that customers can use for practice. (3) The use of this kit is simple. Compared with the complicated reagent components in the real kit, the simulated kit selects and tests the reagents for the performance and then places the reagents that can be combined in the same reagent tube. This shortens the verification time and improves the verification efficiency, so that relevant personnel with weak biological skills can also use this kit proficiently after simple training. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 Shown is a schematic diagram of the chip structure and sample loading wells for single-cell sequencing instrument verification.

[0022] Figure 2 Flow chart showing the use of the mock kit for single-cell sequencing instrument validation. DETAILED DESCRIPTION

[0023] The following describes the embodiments of the present invention through specific examples, and those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. The present invention can also be implemented or applied through other different specific embodiments, and the details in this specification can also be modified or changed in various ways based on different viewpoints and applications without departing from the spirit of the present invention.

[0024] It should be noted that the process equipment or devices not specifically specified in the following embodiments are all conventional equipment or devices in the art.

[0025] Before further describing the specific embodiments of the present invention, it should be understood that the scope of protection of the present invention is not limited to the specific embodiments described below; it should also be understood that the terms used in the examples of the present invention are for describing the specific embodiments rather than for limiting the scope of protection of the present invention; in the present specification and claims, unless otherwise expressly stated herein, the singular forms "a", "an" and "the" include plural forms.

[0026] When the embodiments give numerical ranges, it should be understood that, unless otherwise specified in the present invention, both endpoints of each numerical range and any numerical value between the two endpoints can be selected. Unless otherwise defined, all technical and scientific terms used in the present invention have the same meaning as those generally understood by those skilled in the art. In addition to the specific methods, equipment, and materials used in the embodiments, according to the grasp of the prior art by those skilled in the art and the record of the present invention, any methods, equipment, and materials of the prior art similar or equivalent to the methods, equipment, and materials described in the embodiments of the present invention can also be used to realize the present invention.

[0027] Unless otherwise stated, the experimental methods, detection methods, and preparation methods disclosed in the present invention all adopt conventional techniques in the field of molecular biology, biochemistry, chromatin structure and analysis, analytical chemistry, cell culture, recombinant DNA technology, and related fields.

[0028] Example 1 The embodiment of the present application provides a specific single-cell sequencing instrument verification simulation kit, including simulated microspheres, simulated cell phases, simulated reverse transcription reagents, and simulated droplet generation oil, all of which are stored at room temperature.

[0029] The simulated cell phase is composed of the following components in percentage by weight: 83% phosphate buffered saline (PBS), 15% density gradient medium (optiprep, opt) and 2% polyethylene glycol.

[0030] The simulated reverse transcription reagent comprises a simulated reverse transcription primer, a simulated reverse transcription buffer and a simulated reverse transcriptase mixed solution.

[0031] The simulated reverse transcription primer is a mixture of 10 mM Tris-HCl (pH 8.0) and 0.1 mM EDTA.

[0032] The simulated reverse transcription buffer includes the following components: 100mM Tris-HCl (pH 8.3), 200mM KCL, 7mM MgCl2, 25mM DTT, 0.25 Vol% non-ionic surfactant CA630 and 5mM dNTP Mix solution (Sangon, Dntp mix 25mM dilution). The dNTP Mix solution is a mixture of equimolar nucleic acids of dATP, dCTP, dGTP and dTTP, and the final concentration of each nucleic acid solution is 25 mM.

[0033] The simulated reverse transcriptase mixture includes the following components: 15mM EDTA; 40mM NaCl, 20mM Tris-Hcl with a pH of 7.5, 5mM Tris-Hcl with a pH of 8.0, 0.05 Vol% non-ionic surfactant CA630, 3.5mM DTT, 37 Vol% glycerol, 15% mM KCl, and 25 Vol% polyethylene glycol PEG600.

[0034] The simulated droplet generation oil is a fluorinated surfactant, specifically HFE7500 fluorinated oil.

[0035] Example 2 The embodiment of the present application provides a specific single-cell sequencing instrument verification simulation kit, including simulated microspheres, simulated cell phases, simulated reverse transcription reagents, and simulated droplet generation oil, all of which are stored at room temperature.

[0036] The simulated cell phase is composed of the following components in percentage by weight: 75% phosphate buffered saline (PBS), 20% density gradient medium (optiprep, opt) and 5% polyethylene glycol.

[0037] The simulated reverse transcription reagent comprises a simulated reverse transcription primer, a simulated reverse transcription buffer and a simulated reverse transcriptase mixed solution.

[0038] The simulated reverse transcription primer is a mixture of 15 mM Tris-HCl (pH 8.0) and 0.2 mM EDTA.

[0039] The simulated reverse transcription buffer includes the following components: 75mM Tris-HCl with a pH of 8.3, 150mM KCL, 5mM MgCl2, 20mM DTT, 0.1 Vol% non-ionic surfactant CA630 and 2mM dNTP Mix solution (Sangon, Dntp mix 25mM dilution). The dNTP Mix solution is an equimolar mixture of nucleic acids including dATP, dCTP, dGTP and dTTP, and the final concentration of each nucleic acid solution is 25 mM.

[0040] The simulated reverse transcriptase mixture includes the following components: 10mM EDTA; 30mM NaCl, 15mM Tris-Hcl with a pH of 7.5, 10mM Tris-Hcl with a pH of 8.0, 0.003 Vol% non-ionic surfactant CA630, 5mM DTT, 55 Vol% glycerol, 10mM KCl, and 30 Vol% polyethylene glycol PEG600.

[0041] The simulated droplet generation oil is a fluorinated surfactant, specifically HFE7500 fluorinated oil.

[0042] Example 3 The embodiment of the present application provides a specific single-cell sequencing instrument verification simulation kit, including simulated microspheres, simulated cell phases, simulated reverse transcription reagents, and simulated droplet generation oil, all of which are stored at room temperature.

[0043] The simulated cell phase is composed of the following components in percentage by weight: 85% phosphate buffered saline (PBS), 10% density gradient medium (optiprep, opt) and 5% polyethylene glycol.

[0044] The simulated reverse transcription reagent comprises a simulated reverse transcription primer, a simulated reverse transcription buffer and a simulated reverse transcriptase mixed solution.

[0045] The simulated reverse transcription primer is a mixture of 12 mM Tris-HCl (pH 8.0) and 0.15 mM EDTA.

[0046] The simulated reverse transcription buffer includes the following components: 85mM Tris-HCl (pH 8.3), 170mM KCL, 6mM MgCl2, 25mM DTT, 0.15 Vol% non-ionic surfactant CA630 and 2.5mM dNTP Mix solution (Sangon, Dntp mix 25mM dilution). The dNTP Mix solution is a mixture of equimolar nucleic acids of dATP, dCTP, dGTP and dTTP, and the final concentration of each nucleic acid solution is 25 mM.

[0047] The simulated reverse transcriptase mixture includes the following components: 12mM EDTA; 35mM NaCl, 16mM Tris-Hcl with a pH of 7.5, 8mM Tris-Hcl with a pH of 8.0, 0.035 Vol% non-ionic surfactant CA630, 3mM DTT, 30 Vol% glycerol, 12mM KCl, and 20 Vol% polyethylene glycol PEG600.

[0048] The simulated droplet generation oil is a fluorinated surfactant, specifically HFE7500 fluorinated oil.

[0049] Comparative Example The difference between the comparative example and the embodiment is that the kit is different. The comparative example uses a real kit to verify the high-throughput single-cell instrument, and the verification method is exactly the same as that of the embodiment.

[0050] The actual kit in this comparative example uses MobiCube® High-throughput Single-cell 3' Transcriptome Kit from MozoBio.

[0051] The MobiCube® High-throughput 3' Single-Cell Transcriptome Kit can be used in conjunction with the MobiNova@-100 High-throughput Single-Cell Sequencing Library Construction System to quickly complete the construction of transcriptome sequencing libraries for hundreds to tens of thousands of single cells.

[0052] MobiCube® High-throughput Single-cell 3' Transcriptome Kit is composed of a microsphere kit, a reverse transcription kit and a library construction kit. The microsphere kit and the reverse transcription kit are used to match the instrument, which is similar to the use of the analog reagents.

[0053] The microsphere kit contains 3' transcriptome microspheres (hydrogel microspheres with capture sequences) and reverse transcription primers (containing oligonucleotide sequences); the reverse transcription kit contains reverse transcriptase mixture (containing reverse transcriptase), reverse transcription buffer and reverse transcription enhancer. Use in accordance with the product SOP.

[0054] like Figure 2 As shown, the present application uses the single-cell sequencing instrument verification simulation kits of Example 1, Example 2, Example 3 and the comparative example to verify the high-throughput single-cell instrument respectively. The high-throughput single-cell instrument used is MobiNova®-100 high-throughput single-cell sequencing library construction system of Mozo Bio, which specifically includes the following steps: (1) Preparation of simulated reverse transcription reagents: Single cell capture chip preparation in this application: The chip, gasket, and chip holder are all stored at room temperature.

[0055] Prepare the simulated reverse transcription reagent according to Table 1 according to the number of flow channels required for the chip. Before use, flick each reagent upside down and mix it 5 times with your fingers, then centrifuge it for standby use. After the simulated reverse transcription reagent is prepared, pipette it 15 times or vortex it to mix it, then centrifuge it for standby use. Prepare the simulated cell phase: take out the simulated cell phase, centrifuge it for 10 seconds, and set it aside; prepare the simulated microspheres: take out the simulated microspheres, vortex it for 10 seconds, centrifuge it for 10 seconds, and set it aside; Table 1. Reagent formula for simulated reverse transcription Note: To avoid insufficient reagents, you need to prepare more than the actual amount when loading the machine. For example, if only one flow channel is used, prepare according to 1.1x redundancy, that is, prepare according to 1.1 times the actual amount.

[0056] (2) Add reagents: Figure 1 Corresponding reagents are added to the cups of each chip shown, and B, C, D, and E correspond to: simulated microspheres, simulated cell phase, simulated reverse transcription reagents, and simulated droplet generation oil, respectively.

[0057] Specifically: slowly push out the simulated microspheres (about 15 seconds) and add them to the cup marked B. Avoid bubbles during the addition process; slowly add 45 μL of simulated cell phase reagent to the cup marked C to avoid bubbles; slowly add 80 μL of simulated reverse transcription reagent to the cup marked D to avoid bubbles; add 160 μL of droplet generation oil HFE7500 fluorinated oil to the cup marked E; (3) running high-throughput single-cell instruments; (4) Conduct quality inspection on the operation results.

[0058] The single-cell sequencing instrument verification simulation kits of Example 1, Example 2, and Example 3 were used to compare with the real kits of the comparative example, and a verification experiment was performed on the high-throughput single-cell instrument. The experimental results are shown in Table 2: Table 2. Instrument verification results As can be seen from Table 2, the single-cell sequencing instrument verification simulation kit of the embodiment and the real kit of the comparative example are very close in terms of the five indicators of droplet success rate, cell consumption ratio, RT consumption ratio, single package rate, and multiple package rate, and can replace the real reagents to test the performance of the instrument.

[0059] In summary, the cell sequencing instrument verification simulation kit of the present invention can highly simulate the real test kit in terms of physical and chemical properties, ensuring that the test effect consistent with the actual use environment is achieved during the verification process, thereby reducing the verification cost and improving the verification efficiency; the cell sequencing instrument verification simulation kit of the present invention can be stored at room temperature, that is, different from the characteristics of real experimental reagents that often need to be stored at low temperatures and are not easy to transport, the room temperature storage and transportation of the cell sequencing instrument verification simulation kit of the present invention greatly reduces the cost, and it is also a test kit that customers can use for practice; the use and operation of the cell sequencing instrument verification simulation kit of the present invention is simple, compared with the complicated reagent components in the real test kit, the simulation test kit is selected and tested through the reagent performance, and the reagents that can be combined are placed in the same reagent tube; the verification time is shortened, the verification efficiency is improved, and the relevant personnel with weak biological skills can also use the test kit proficiently after simple training. Therefore, the present invention effectively overcomes the various shortcomings in the prior art and has a high industrial utilization value.

[0060] The above embodiments are merely illustrative of the principles and effects of the present invention, and are not intended to limit the present invention. Anyone familiar with the art may modify or alter the above embodiments without departing from the spirit and scope of the present invention. Therefore, all equivalent modifications or alterations made by a person of ordinary skill in the art without departing from the spirit and technical concept disclosed by the present invention shall still be covered by the claims of the present invention.

Claims

1. A single-cell sequencing instrument verification simulation kit, characterized in that: The system comprises simulated microspheres, simulated cell phases, simulated reverse transcription reagents and simulated droplet generation oil. The simulated microspheres do not contain captured oligonucleotides, the simulated reverse transcription reagents do not contain active enzymes, and the simulated cell phases do not contain cells.

2. The single-cell sequencing instrument verification simulation kit according to claim 1, characterized in that: The simulated microspheres are hydrogel microspheres that do not contain capture oligonucleotides.

3. The single-cell sequencing instrument verification simulation kit according to claim 1, characterized in that: The simulated cell phase is composed of the following components in percentage by mass: 75-85% phosphate buffered saline, 10-20% density gradient culture medium and 2-5% polyethylene glycol.

4. The single-cell sequencing instrument verification simulation kit according to claim 1, characterized in that: The simulated reverse transcription reagent comprises a simulated reverse transcription primer, a simulated reverse transcription buffer and a simulated reverse transcriptase mixed solution.

5. The single-cell sequencing instrument verification simulation kit according to claim 4, characterized in that: The simulated reverse transcription primer is a mixture of tris(hydroxymethyl)aminomethane hydrochloride with a concentration of 10-15 mM and EDTA with a concentration of 0.1-0.2 mM.

6. The single-cell sequencing instrument verification simulation kit according to claim 4, characterized in that: The simulated reverse transcription buffer includes the following components: 75~100mM tris(hydroxymethyl)aminomethane hydrochloride with a pH of 8.3, 150~200mM KCL, 5~7mM MgCl2, 20~25mM DTT, 0.1~0.25Vol% non-ionic surfactant and 2~5mM dNTP Mix solution.

7. The single-cell sequencing instrument verification simulation kit according to claim 4, characterized in that: The simulated reverse transcriptase mixture includes the following components: 10-15 mM EDTA; 30-40 mM NaCl, 15-20 mM tris(hydroxymethyl)aminomethane hydrochloride with a pH of 7.5, 5-10 mM tris(hydroxymethyl)aminomethane hydrochloride with a pH of 8.0, 0.003-0.05 Vol% non-ionic surfactant, 3-5 mM DTT, 30-55 Vol% glycerol, 10-15 mM KCl, and 20-30 Vol% polyethylene glycol.

8. The single-cell sequencing instrument verification simulation kit according to claim 1, characterized in that: The simulated droplet formation oil is a fluorinated surfactant.

9. A use of the single-cell sequencing instrument verification simulation kit as described in any one of claims 1 to 8 for verifying a single-cell sequencing instrument.

10. A method for using the single-cell sequencing instrument verification simulation kit according to any one of claims 1 to 8, characterized in that: The method is used in conjunction with a high-throughput single-cell instrument, comprising the following steps: adding the components of the single-cell sequencing instrument verification simulation kit to the chip of the high-throughput single-cell instrument, running the high-throughput single-cell instrument, and performing quality inspection on the running results.